Details of the Drug
General Information of Drug (ID: DMKS0J0)
| Drug Name |
Vatiquinone
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
alpha-Tocotrienol quinone; UNII-6O85FK9I0X; 1213269-98-7; 6O85FK9I0X; Vatiquinone [USAN:INN]; Vatiquinone (JAN/USAN); SCHEMBL503125; (R)-Alpha-Tocotrienol Quinone; CHEMBL1812161; SCHEMBL14639355; DTXSID90153231; LNOVHERIIMJMDG-XZXLULOTSA-N; DB11917; 2,5-Cyclohexadiene-1,4-dione, 2-((3R,6e,10E)-3-hydroxy-3,7,11,15-tetramethyl-6,10,14-hexadecatrien-1-yl)-3,5,6-trimethyl-; D10407
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||

